Revance Therapeutics, Inc. - Common Stock

$34.10 -$0.10 -0.29%

Own 1 of RVNC at $34.50 which is 0.06% of the portfolio.

-$0.40 (-1.16%)

Shares Bought1
Shares Sold0
Shares Owned1
Last Price$34.10
Total Return-$0.40
Range Today$33.32 - $34.75
52 Week Range$16.40 - $37.20
Market Cap$1.05B
P/E Ratio-

Revance Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages on the development, manufacturing, and commercialization of novel botulinum toxin products for multiple aesthetic, and therapeutic applications. It focuses on the development of daxibotulinumtoxinA, a botulinum toxin, for a broad spectrum of aesthetic and therapeutic indications, including facial wrinkles and muscle movement disorders. The company was founded by Jacob M. Waugh and L. Daniel Browne on August 10, 1999 and is headquartered in Newark, CA.

Open Positions

Buy Date Buy Price Quote Return $ Return % Owners
12-06-17 14:32 $34.50 $34.10 -$0.40 -1.16% davidb1127

Closed Positions

Buy Date Sell Date Buy Price Sell Price Return $ Return % Owners